vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and PHOTRONICS INC (PLAB). Click either name above to swap in a different company.
PHOTRONICS INC is the larger business by last-quarter revenue ($210.4M vs $168.4M, roughly 1.2× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -5.5%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -3.8%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Photronics, Inc. is an American semiconductor photomask manufacturer. It was the third largest photomask supplier globally as of 2009. Photronics is a member of the eBeam Initiative.
ESPR vs PLAB — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $210.4M |
| Net Profit | — | $22.9M |
| Gross Margin | — | 33.7% |
| Operating Margin | 50.6% | 22.9% |
| Net Margin | — | 10.9% |
| Revenue YoY | 143.7% | -5.5% |
| Net Profit YoY | — | -32.4% |
| EPS (diluted) | $0.32 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | — | ||
| Q3 25 | $87.3M | $210.4M | ||
| Q2 25 | $82.4M | $211.0M | ||
| Q1 25 | $65.0M | $212.1M | ||
| Q4 24 | $69.1M | $222.6M | ||
| Q3 24 | $51.6M | $211.0M | ||
| Q2 24 | $73.8M | $217.0M | ||
| Q1 24 | $137.7M | $216.3M |
| Q4 25 | — | — | ||
| Q3 25 | $-31.3M | $22.9M | ||
| Q2 25 | $-12.7M | $8.9M | ||
| Q1 25 | $-40.5M | $42.9M | ||
| Q4 24 | — | $33.9M | ||
| Q3 24 | $-29.5M | $34.4M | ||
| Q2 24 | $-61.9M | $36.3M | ||
| Q1 24 | $61.0M | $26.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | 33.7% | ||
| Q2 25 | — | 36.9% | ||
| Q1 25 | — | 35.6% | ||
| Q4 24 | — | 37.0% | ||
| Q3 24 | — | 35.6% | ||
| Q2 24 | — | 36.5% | ||
| Q1 24 | — | 36.6% |
| Q4 25 | 50.6% | — | ||
| Q3 25 | -11.4% | 22.9% | ||
| Q2 25 | 8.6% | 26.4% | ||
| Q1 25 | -34.0% | 24.6% | ||
| Q4 24 | -6.4% | 25.1% | ||
| Q3 24 | -31.0% | 24.7% | ||
| Q2 24 | 3.5% | 25.8% | ||
| Q1 24 | 52.5% | 26.6% |
| Q4 25 | — | — | ||
| Q3 25 | -35.9% | 10.9% | ||
| Q2 25 | -15.4% | 4.2% | ||
| Q1 25 | -62.2% | 20.2% | ||
| Q4 24 | — | 15.2% | ||
| Q3 24 | -57.2% | 16.3% | ||
| Q2 24 | -83.9% | 16.7% | ||
| Q1 24 | 44.3% | 12.1% |
| Q4 25 | $0.32 | — | ||
| Q3 25 | $-0.16 | $0.39 | ||
| Q2 25 | $-0.06 | $0.15 | ||
| Q1 25 | $-0.21 | $0.68 | ||
| Q4 24 | $-0.14 | $0.54 | ||
| Q3 24 | $-0.15 | $0.55 | ||
| Q2 24 | $-0.33 | $0.58 | ||
| Q1 24 | $0.34 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $575.8M |
| Total DebtLower is stronger | — | $16.0K |
| Stockholders' EquityBook value | $-302.0M | $1.1B |
| Total Assets | $465.9M | $1.8B |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | — | ||
| Q3 25 | $92.4M | $575.8M | ||
| Q2 25 | $86.1M | $558.4M | ||
| Q1 25 | $114.6M | $642.2M | ||
| Q4 24 | $144.8M | $640.7M | ||
| Q3 24 | $144.7M | $606.4M | ||
| Q2 24 | $189.3M | $559.9M | ||
| Q1 24 | $226.6M | $521.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $16.0K | ||
| Q2 25 | — | $19.0K | ||
| Q1 25 | — | $21.0K | ||
| Q4 24 | — | $25.0K | ||
| Q3 24 | — | $28.0K | ||
| Q2 24 | — | $2.5M | ||
| Q1 24 | — | $2.7M |
| Q4 25 | $-302.0M | — | ||
| Q3 25 | $-451.4M | $1.1B | ||
| Q2 25 | $-433.5M | $1.1B | ||
| Q1 25 | $-426.2M | $1.1B | ||
| Q4 24 | $-388.7M | $1.1B | ||
| Q3 24 | $-370.2M | $1.1B | ||
| Q2 24 | $-344.2M | $1.0B | ||
| Q1 24 | $-294.3M | $1.0B |
| Q4 25 | $465.9M | — | ||
| Q3 25 | $364.0M | $1.8B | ||
| Q2 25 | $347.1M | $1.7B | ||
| Q1 25 | $324.0M | $1.7B | ||
| Q4 24 | $343.8M | $1.7B | ||
| Q3 24 | $314.1M | $1.6B | ||
| Q2 24 | $352.3M | $1.6B | ||
| Q1 24 | $373.1M | $1.6B |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $50.1M |
| Free Cash FlowOCF − Capex | — | $25.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | 0.0% | 11.8% |
| Cash ConversionOCF / Net Profit | — | 2.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $64.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | — | ||
| Q3 25 | $-4.3M | $50.1M | ||
| Q2 25 | $-31.4M | $31.5M | ||
| Q1 25 | $-22.6M | $78.5M | ||
| Q4 24 | $-35.0M | $68.4M | ||
| Q3 24 | $-35.3M | $75.1M | ||
| Q2 24 | $-7.2M | $76.5M | ||
| Q1 24 | $53.8M | $41.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $25.2M | ||
| Q2 25 | — | $-29.1M | ||
| Q1 25 | — | $43.3M | ||
| Q4 24 | — | $25.2M | ||
| Q3 24 | $-35.5M | $50.7M | ||
| Q2 24 | $-7.3M | $56.5M | ||
| Q1 24 | $53.8M | $-1.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | 12.0% | ||
| Q2 25 | — | -13.8% | ||
| Q1 25 | — | 20.4% | ||
| Q4 24 | — | 11.3% | ||
| Q3 24 | -68.7% | 24.0% | ||
| Q2 24 | -9.9% | 26.0% | ||
| Q1 24 | 39.0% | -0.8% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 11.8% | ||
| Q2 25 | 0.0% | 28.7% | ||
| Q1 25 | 0.0% | 16.6% | ||
| Q4 24 | 0.0% | 19.4% | ||
| Q3 24 | 0.3% | 11.6% | ||
| Q2 24 | 0.1% | 9.2% | ||
| Q1 24 | 0.1% | 20.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.19× | ||
| Q2 25 | — | 3.55× | ||
| Q1 25 | — | 1.83× | ||
| Q4 24 | — | 2.02× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.11× | ||
| Q1 24 | 0.88× | 1.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
PLAB
| High End Integrated Circuits | $53.6M | 25% |
| High End Flat Panel Displays | $53.5M | 25% |
| KR | $43.7M | 21% |
| Other | $42.1M | 20% |
| Mainstream Flat Panel Displays | $9.1M | 4% |
| Transferred At Point In Time | $8.4M | 4% |
